Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes

Abstract

This study provides Class II evidence that antibodies to glycolipids are increased in patients with acute motor axonal neuropathy and acute motor conduction block neuropathy but not acute inflammatory demyelinating polyneuropathy.